201
Participants
Start Date
March 12, 2024
Primary Completion Date
November 28, 2024
Study Completion Date
November 28, 2024
Research Site, Dakahlia
Research Site, Sharkia
Research Site, Alexandria
Research Site, Cairo
Lead Sponsor
AstraZeneca
INDUSTRY